Benitec Biopharma Inc.
Prognozy (mln)
Okres |
2024-06-30 |
2025-06-30 |
2026-06-30 |
2027-06-30 |
2028-06-30 |
2029-06-30 |
Przychód (średnia) |
0.15 |
1.15 |
39.01 |
95.81 |
60.37 |
145.19 |
Przychód Δ r/r |
0.00% |
668.63% |
3290.48% |
145.58% |
-36.99% |
140.50% |
Przychód (min) |
0.15 |
1.15 |
39.01 |
95.81 |
60.37 |
145.19 |
Przychód (max) |
0.15 |
1.15 |
39.01 |
95.81 |
60.37 |
145.19 |
EBITDA (średnia) |
-0.15 |
-1.15 |
-39.01 |
-95.81 |
-60.37 |
-145.19 |
EBIT (średnia) |
-0.15 |
-1.15 |
-39.01 |
-95.81 |
-60.37 |
-145.19 |
EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
Zysk netto (średni) |
-73.69 |
-26.49 |
-53.35 |
-28.73 |
-21.13 |
12.33 |
Zysk netto % |
-49220.31% |
-2302.04% |
-136.74% |
-29.98% |
-35.01% |
8.49% |
EPS (średnia) |
-7.17 |
-1.88 |
-2.41 |
-2.88 |
-1.72 |
1.20 |
Liczba analityków (Przychody) |
1 |
4 |
7 |
4 |
3 |
1 |
Liczba analityków (EPS) |
2 |
4 |
4 |
4 |
3 |
1 |
symbol |
BNTC |
BNTC |
BNTC |
BNTC |
BNTC |
BNTC |